The model combines artificial intelligence and insights into an epigeneticbased biological program that is shared by most cancers. Earlier this year Harbinger found its test has 82 overall sensitivity of cancer detection at 95 specificity in a study of 1046 subjects. Most or 621 of the subjects had newly diagnosed treatmentnaive cancer